← Back to catalogue

Dario Blood Glucose Monitoring System

FDA UDI

Class II (US FDA UDI)

by Labstyle Innovation Ltd

Identity

Trade Name
Dario Blood Glucose Monitoring System FDA UDI
Generic Name
Glucose monitoring system IVD, home-use FDA UDI
Device Name
The Dario Blood Glucose Monitoring System is intended for self-testing outside the body (in vitro diagnostic use) by people with diabetes at home to monitor the effectiveness of diabetes control. FDA UDI
Model / Reference
1015-05 FDA UDI
Description
The Dario Blood Glucose Monitoring System is intended for self-testing outside the body (in vitro diagnostic use) by people with diabetes at home to monitor the effectiveness of diabetes control. FDA UDI

Identifiers

Primary DI / UDI-DI
00850065006161 FDA UDI
510(k) Number
K150817 FDA UDI
K163159 FDA UDI
FDA Product Code
NBW FDA UDI
GMDN Term
Glucose monitoring system IVD, home-use FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
862.1345 FDA UDI
Commercial Distribution
Not in Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

No

FDA UDI

Over-the-Counter

Yes

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

Yes

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

Yes

FDA UDI

Dario Blood Glucose Monitoring System by Labstyle Innovation Ltd — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Cleared under the same submission

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI 85648e34-a1e9-4c98-8d98-e8f78aa93d0c 35 fields · synced May 31, 2026